PortfoliosLab logoPortfoliosLab logo
GGRP vs. AYTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GGRP vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Glimpse Group, Inc. (GGRP) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GGRP achieves a -15.98% return, which is significantly lower than AYTU's -11.92% return.


GGRP

1D
-0.89%
1M
53.63%
YTD
-15.98%
6M
-25.90%
1Y
-51.07%
3Y*
-41.92%
5Y*
10Y*

AYTU

1D
1.78%
1M
-8.40%
YTD
-11.92%
6M
2.23%
1Y
14.50%
3Y*
12.70%
5Y*
-53.73%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GGRP vs. AYTU - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GGRP
The Glimpse Group, Inc.
-15.98%-62.51%118.58%-62.71%-69.27%-44.17%
AYTU
Aytu BioPharma, Inc.
-11.92%52.94%-40.14%-24.87%-86.00%-73.63%

Correlation

The correlation between GGRP and AYTU is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2021

0.20

The correlation between GGRP and AYTU shifts across timeframes, from 0.09 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GGRP:

$16.40M

AYTU:

$24.07M

EPS

GGRP:

-$0.72

AYTU:

-$2.91

PS Ratio

GGRP:

2.37

AYTU:

0.47

PB Ratio

GGRP:

6.06

AYTU:

0.68

Total Revenue (TTM)

GGRP:

$6.85M

AYTU:

$56.60M

Gross Profit (TTM)

GGRP:

$4.52M

AYTU:

$36.14M

EBITDA (TTM)

GGRP:

-$4.34M

AYTU:

-$27.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GGRP vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GGRP
GGRP Risk / Return Rank: 1818
Overall Rank
GGRP Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
GGRP Sortino Ratio Rank: 2020
Sortino Ratio Rank
GGRP Omega Ratio Rank: 2222
Omega Ratio Rank
GGRP Calmar Ratio Rank: 1616
Calmar Ratio Rank
GGRP Martin Ratio Rank: 1717
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 5151
Overall Rank
AYTU Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4949
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4949
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5252
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GGRP vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Glimpse Group, Inc. (GGRP) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GGRPAYTUDifference
Sharpe ratioReturn per unit of total volatility

-0.84

Sortino ratioReturn per unit of downside risk

-1.29

Omega ratioGain probability vs. loss probability

0.94

1.10

-0.15

Calmar ratioReturn relative to maximum drawdown

-0.70

0.41

-1.11

Martin ratioReturn relative to average drawdown

-1.15

0.97

-2.13

GGRP vs. AYTU - Sharpe Ratio Comparison

The current GGRP Sharpe Ratio is -0.58, which is lower than the AYTU Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of GGRP and AYTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GGRPAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.58

0.27

-0.84

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.63

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.43

-0.36

-0.07

Drawdowns

GGRP vs. AYTU - Drawdown Comparison

The maximum GGRP drawdown since its inception was -97.25%, roughly equal to the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for GGRP and AYTU.


Loading charts...

Drawdown Indicators


GGRPAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-97.25%

-100.00%

+2.75%

Max Drawdown (1Y)

Largest decline over 1 year

-73.15%

-35.47%

-37.68%

Max Drawdown (3Y)

Largest decline over 3 years

-88.23%

-70.24%

-17.99%

Max Drawdown (5Y)

Largest decline over 5 years

-99.12%

Current Drawdown

Current decline from peak

-95.59%

-100.00%

+4.41%

Average Drawdown

Average peak-to-trough decline

-80.96%

-95.15%

+14.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.33%

14.92%

+29.41%

Volatility

GGRP vs. AYTU - Volatility Comparison

The Glimpse Group, Inc. (GGRP) has a higher volatility of 35.02% compared to Aytu BioPharma, Inc. (AYTU) at 14.09%. This indicates that GGRP's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GGRPAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

35.02%

14.09%

+20.93%

Volatility (6M)

Calculated over the trailing 6-month period

64.80%

33.39%

+31.41%

Volatility (1Y)

Calculated over the trailing 1-year period

88.93%

55.06%

+33.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

108.79%

85.66%

+23.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

108.79%

188.20%

-79.41%

Dividends

GGRP vs. AYTU - Dividend Comparison

Neither GGRP nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

GGRP vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between The Glimpse Group, Inc. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
657.46K
12.41M
(GGRP) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


GGRP and AYTU have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GGRP has higher volatility (35.02%) compared to AYTU (14.09%). In terms of maximum drawdown, GGRP dropped -97.25% vs AYTU's -100.00%.

AYTU currently has the higher Sharpe Ratio (0.27 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GGRP and AYTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer